A business in context
FENC research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-15 | Brughera Marco Maria | M · Exercise / conversion | Common Shares | 15545.0 | 2.11 |
| 2026-09-15 | Brughera Marco Maria | S · Sale | Common Shares | 15545.0 | 10.29 |
| 2026-09-15 | Brughera Marco Maria | M · Exercise / conversion | Stock Option | 15545.0 | 0.0 |
| 2026-09-01 | Raykov Rosty | S · Sale | Common shares | 10000.0 | 12.11 |
| 2026-08-31 | Cioffi Christiana Marie | A · Grant / award | Common shares | 156.0 | 0.0 |
| 2026-08-31 | Sayad Pierre Sargis | A · Grant / award | Common Shares | 168.0 | 0.0 |
| 2026-08-31 | Sayad Pierre Sargis | S · Sale | Common Shares | 12000.0 | 12.18 |
| 2026-08-31 | Evans Terry L | A · Grant / award | Common Shares | 168.0 | 0.0 |
| 2026-08-31 | Hackman Jeffrey S. | A · Grant / award | Common Shares | 1159.0 | 0.0 |
| 2026-08-31 | Raykov Rosty | A · Grant / award | Common shares | 2778.0 | 0.0 |
| 2026-08-31 | Andrade Robert | A · Grant / award | Common shares | 1703.0 | 0.0 |
| 2026-08-28 | Andrade Robert | M · Exercise / conversion | Common shares | 21928.0 | 5.1 |
| 2026-08-28 | Andrade Robert | M · Exercise / conversion | Stock Options | 21928.0 | 0.0 |
| 2026-08-27 | Andrade Robert | S · Sale | Common shares | 75000.0 | 11.78 |
| 2026-08-03 | Raykov Rosty | S · Sale | Common shares | 10000.0 | 9.58 |
| 2026-07-31 | Cioffi Christiana Marie | A · Grant / award | Common shares | 156.0 | 0.0 |
| 2026-07-31 | Sayad Pierre Sargis | A · Grant / award | Common Shares | 168.0 | 0.0 |
| 2026-07-31 | Evans Terry L | A · Grant / award | Common Shares | 168.0 | 0.0 |
| 2026-07-31 | Hackman Jeffrey S. | A · Grant / award | Common Shares | 1159.0 | 0.0 |
| 2026-07-31 | Raykov Rosty | A · Grant / award | Common shares | 2778.0 | 0.0 |
| 2026-07-31 | Andrade Robert | A · Grant / award | Common shares | 1703.0 | 0.0 |
| 2026-07-01 | Raykov Rosty | A · Grant / award | Common shares | 2778.0 | 0.0 |
| 2026-07-01 | Raykov Rosty | M · Exercise / conversion | Common shares | 15597.0 | 2.45 |
| 2026-07-01 | Raykov Rosty | S · Sale | Common shares | 9599.0 | 10.41 |
| 2026-07-01 | Raykov Rosty | M · Exercise / conversion | Stock Options | 15597.0 | 2.45 |
| 2026-06-30 | Cioffi Christiana Marie | A · Grant / award | Common shares | 156.0 | 0.0 |
| 2026-06-30 | Sayad Pierre Sargis | A · Grant / award | Common Shares | 168.0 | 0.0 |
| 2026-06-30 | Evans Terry L | A · Grant / award | Common Shares | 168.0 | 0.0 |
| 2026-06-30 | Hackman Jeffrey S. | A · Grant / award | Common Shares | 1159.0 | 0.0 |
| 2026-06-30 | Andrade Robert | A · Grant / award | Common shares | 1703.0 | 0.0 |
Identity & relationships
SEC issuer · 0001211583FENNEC PHARMACEUTICALS INC.
Search names and former names
- ADHEREX TECHNOLOGIES INC · former SEC name · 2002-12-10 to 2014-08-14
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $47.54M | $51.06M |
| 2023-12-31 | $21.25M | $23.50M |
| 2022-12-31 | $1.53M | $1.77M |
| 2020-12-31 | $170.0K | $221.3K |
| 2019-12-31 | $0 | $0 |
| 2018-12-31 | $0 | $0 |
| 2017-12-31 | $0 | $0 |